Making Prodrugs Stick Around: Engineering Protease-Activated Tumor Retention
ACS Central Science · 22.07.2026 · 12 (7) · 888-890
DOI: 10.1021/acscentsci.6c01098 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Central Science, online erschienen am 09.07.2026. Verfasst von Robin Kryštůfek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organic Chemistry and Biochemistry, Academy of Science of the Czech Republic, Flemingovo n. 2, 166 10 Praha 6, Czech Republic. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kang et al. combine protease-triggered activation with membrane trapping, keeping drugs in tumors longer and boosting delivery, imaging, and therapy.
Autor:innen und Institutionen
- Institute of Organic Chemistry and Biochemistry, Academy of Science of the Czech Republic, Flemingovo n. 2, 166 10 Praha 6, Czech Republic.
ORCID-Profile: Jan Konvalinka
Zitieren
APA
Kryštůfek, R., & Konvalinka, J. (2026). Making Prodrugs Stick Around: Engineering Protease-Activated Tumor Retention. ACS Central Science, 12(7), 888-890. https://doi.org/10.1021/acscentsci.6c01098
Vancouver
Kryštůfek R, Konvalinka J. Making Prodrugs Stick Around: Engineering Protease-Activated Tumor Retention. ACS Central Science. 2026;12(7):888-890. doi:10.1021/acscentsci.6c01098
BibTeX
@article{Krytfek2026,
author = {Kryštůfek, Robin and Konvalinka, Jan},
title = {Making Prodrugs Stick Around: Engineering Protease-Activated Tumor Retention},
journal = {ACS Central Science},
year = {2026},
volume = {12},
number = {7},
pages = {888--890},
doi = {10.1021/acscentsci.6c01098}
}
EUVIMED